- Home
- HUM vs BNTX Comparison
HUM vs BNTX Comparison
Compare HUM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUM | BNTX |
|---|---|---|
| Founded | 1961 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.2B | 24.8B |
| IPO Year | 1993 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HUM | BNTX |
|---|---|---|
| Price | $273.74 | $93.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 11 |
| Target Price | ★ $297.87 | $137.40 |
| AVG Volume (30 Days) | ★ 1.5M | 1.3M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.68 | N/A |
| Revenue | ★ $126,362,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $10.81 | $2.36 |
| Revenue Next Year | $11.77 | N/A |
| P/E Ratio | $25.13 | ★ N/A |
| Revenue Growth | ★ 9.87 | 3.70 |
| 52 Week Low | $206.87 | $81.20 |
| 52 Week High | $315.35 | $129.27 |
Technical Indicators
Market Signals| Indicator | HUM | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 63.92 | 36.70 |
| Support Level | $247.53 | $94.52 |
| Resistance Level | $274.99 | $97.35 |
| Average True Range (ATR) | 8.89 | 2.51 |
| MACD | 4.42 | -0.25 |
| Stochastic Oscillator | 97.60 | 4.46 |
Price Performance
Historical ComparisonAbout HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.